PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Symptom | |vascular disease |
| Sentences | 67 |
| PubMedID- 24511540 | Suggests that vegfa polymorphisms do not seem to exert a significant influence on the risk of cardiovascular disease in patients with rheumatoid arthritis 6. |
| PubMedID- 22808986 | Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 23193471 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. |
| PubMedID- 22249350 | Risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 21388351 | Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 22927710 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 22935383 | Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown. |
| PubMedID- 25011482 | Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20952464 | Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. |
| PubMedID- 21981268 | Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23983474 | The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms. |
| PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score frs). |
| PubMedID- 21905005 | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events. |
| PubMedID- 23300117 | Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward). |
| PubMedID- 20164773 | Cardiovascular disease in rheumatoid arthritis: a step forward. |
| PubMedID- 24361194 | Usefulness of the ankle-brachial index as a survey method for subclinical vascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
Page: 1 2